β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceIncome Statement
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue | Cost of Revenue | Gross Profit | Gross Profit Ratio | R&D Expenses | General And Administrative Expenses | Selling And Marketing Expenses | Selling General And Administrative Expenses | Other Expenses | Operating Expenses | Cost And Expenses | Interest Income | Interest Expense | Depreciation And Amortization | EBITDA | EBITDA Ratio | Operating Income | Operating Income Ratio | Total Other Income Expenses Net | Income Before Tax | Income Before Tax Ratio | Income Tax Expense | Net Income | Net Income Ratio | EPS | EPS Diluted | Weighted Average Shares Out | Weighted Average Shares Out Diluted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03 | 301965.0 | 123256.0 | 178709.0 | 0.0 | 25416.0 | 91529.0 | 0.0 | 91529.0 | 23223.0 | 140168.0 | 263424.0 | 1572.0 | 2664.0 | 18178.0 | 50716.0 | 0.16 | 38541.0 | 0.12 | -8667.0 | 29874.0 | 0.09 | 3171.0 | 26642.0 | 0.08 | 72.37 | 72.37 | 368.13 | 368.13 |
2023-03 | 279037.0 | 112950.0 | 166087.0 | 0.0 | 28297.0 | 96257.0 | 0.0 | 96257.0 | 0.0 | 169177.0 | 282127.0 | 1153.0 | 1499.0 | 17249.0 | 12949.0 | 0.04 | -3090.0 | -0.01 | -2709.0 | -5799.0 | -0.02 | 9184.0 | -14948.0 | -0.05 | -38.58 | -38.58 | 387.42 | 387.42 |
2022-03 | 266257.0 | 109671.0 | 156586.0 | 0.0 | 26377.0 | 84499.0 | 0.0 | 84499.0 | 9824.0 | 120700.0 | 230371.0 | 2543.0 | 1209.0 | 17055.0 | 52930.0 | 0.2 | 35886.0 | 0.13 | -270.0 | 35616.0 | 0.13 | 8427.0 | 27218.0 | 0.1 | 68.06 | 67.97 | 399.77 | 400.45 |
2021-03 | 249605.0 | 98221.0 | 151384.0 | 0.0 | 24112.0 | 79554.0 | 0.0 | 79554.0 | 34802.0 | 138468.0 | 236689.0 | 1346.0 | 1488.0 | 17922.0 | 30674.0 | 0.12 | 12917.0 | 0.05 | 231.0 | 12418.0 | 0.04 | 5773.0 | 6830.0 | 0.02 | 17.1 | 17.05 | 399.45 | 400.38 |
2020-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Discover additional income statement data for Santen Pharmaceutical!
Sign up for free or log inπ Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting